Literature DB >> 19390926

Improving outcome for scirrhous gastric cancer.

H H Hartgrink.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19390926     DOI： 10.1007/s10120-009-0501-3

Source DB:  PubMed          Journal:  Gastric Cancer        ISSN： 1436-3291            Impact factor:   7.370


× No keyword cloud information.
  18 in total

1.  Nodal dissection for patients with gastric cancer: a randomised controlled trial.

Authors:  Chew-Wun Wu; Chao A Hsiung; Su-Shun Lo; Mao-Chin Hsieh; Jen-Hao Chen; Anna Fen-Yau Li; Wing-Yiu Lui; Jacqueline Whang-Peng
Journal:  Lancet Oncol       Date:  2006-04       Impact factor: 41.316

Review 2.  Systematic review: Helicobacter pylori eradication for the prevention of gastric cancer.

Authors:  L Fuccio; R M Zagari; M E Minardi; F Bazzoli
Journal:  Aliment Pharmacol Ther       Date:  2007-01-15       Impact factor: 8.171

3.  Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world.

Authors:  Farin Kamangar; Graça M Dores; William F Anderson
Journal:  J Clin Oncol       Date:  2006-05-10       Impact factor: 44.544

4.  An observational study suggesting clinical benefit for adjuvant postoperative chemoradiation in a population of over 500 cases after gastric resection with D2 nodal dissection for adenocarcinoma of the stomach.

Authors:  Sung Kim; Do Hoon Lim; Jeeyun Lee; Won Ki Kang; John S MacDonald; Chan Hyung Park; Se Hoon Park; Se-Hoon Lee; Kihyun Kim; Joon Oh Park; Won Seog Kim; Chul Won Jung; Young Suk Park; Young-Hyuck Im; Tae Sung Sohn; Jae Hyung Noh; Jin Seok Heo; Yong Il Kim; Chul Keun Park; Keunchil Park
Journal:  Int J Radiat Oncol Biol Phys       Date:  2005-08-15       Impact factor: 7.038

5.  Gastric cancer treated in 1991 in Japan: data analysis of nationwide registry.

Authors:  Keiichi Maruyama; Michio Kaminishi; Ken-Ichi Hayashi; Yoh Isobe; Ichiro Honda; Hitoshi Katai; Kuniyoshi Arai; Yasuhiro Kodera; Atsushi Nashimoto
Journal:  Gastric Cancer       Date:  2006       Impact factor: 7.370

6.  Extended lymph node dissection for gastric cancer: who may benefit? Final results of the randomized Dutch gastric cancer group trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; J J Bonenkamp; E Klein Kranenbarg; I Songun; K Welvaart; J H J M van Krieken; S Meijer; J T M Plukker; P J van Elk; H Obertop; D J Gouma; J J B van Lanschot; C W Taat; P W de Graaf; M F von Meyenfeldt; H Tilanus; M Sasako
Journal:  J Clin Oncol       Date:  2004-04-13       Impact factor: 44.544

7.  D2 lymphadenectomy alone or with para-aortic nodal dissection for gastric cancer.

Authors:  Mitsuru Sasako; Takeshi Sano; Seiichiro Yamamoto; Yukinori Kurokawa; Atsushi Nashimoto; Akira Kurita; Masahiro Hiratsuka; Toshimasa Tsujinaka; Taira Kinoshita; Kuniyoshi Arai; Yoshitaka Yamamura; Kunio Okajima
Journal:  N Engl J Med       Date:  2008-07-31       Impact factor: 91.245

8.  Neo-adjuvant chemotherapy for operable gastric cancer: long term results of the Dutch randomised FAMTX trial.

Authors:  H H Hartgrink; C J H van de Velde; H Putter; I Songun; M E T Tesselaar; E Klein Kranenbarg; J E de Vries; J A Wils; J van der Bijl; J H J M van Krieken
Journal:  Eur J Surg Oncol       Date:  2004-08       Impact factor: 4.424

9.  The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

Authors:  Francesco Fiorica; Francesco Cartei; Marco Enea; Anna Licata; Giuseppe Cabibbo; Barbara Carau; Alberto Liboni; Stefano Ursino; Calogero Cammà
Journal:  Cancer Treat Rev       Date:  2007-11-01       Impact factor: 12.111

10.  Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group.

Authors:  A Cuschieri; S Weeden; J Fielding; J Bancewicz; J Craven; V Joypaul; M Sydes; P Fayers
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640
View more
  2 in total

1.  Targeting cadherin-17 inactivates Ras/Raf/MEK/ERK signaling and inhibits cell proliferation in gastric cancer.

Authors:  Zhaohu Lin; Chao Zhang; Meifang Zhang; Danqing Xu; Yanfen Fang; Zheng Zhou; Xiaolong Chen; Ning Qin; Xiongwen Zhang
Journal:  PLoS One       Date:  2014-01-20       Impact factor: 3.240

2.  Detection of circulating stage III-IV gastric cancer tumor cells based on isolation by size of epithelial tumor: using the circulating tumor cell biopsy technology.

Authors:  Rong Lu; Qiang Chen; Xiaoying Liu; Songfei Shen; Zhangchi Pan; Chunmei Shi
Journal:  Transl Cancer Res       Date:  2019-08       Impact factor: 1.241
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.